By Professor Emad El-Omar

Journal articles

Susic DF; Wang L; Roberts LM; Bai M; Gia A; McGovern E; Jiang XT; Davis GK; El-Omar E; Henry A, 2022, 'Corrigendum: The P4 Study: Postpartum Maternal and Infant Faecal Microbiome 6 Months After Hypertensive Versus Normotensive Pregnancy(Front. Cell. Infect. Microbiol., (2022), 12, (646165), 10.3389/fcimb.2022.646165)', Frontiers in Cellular and Infection Microbiology, 12, pp. 895332, http://dx.doi.org/10.3389/fcimb.2022.895332

Zhang N; Wang Z; Lv J; Zhang S; Liu Y; Liu T; Li W; Gong L; Zhang X; El-Omar EM; Lu W, 2022, 'Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion', Frontiers in Medicine, 9, pp. 836369, http://dx.doi.org/10.3389/fmed.2022.836369

Amorim N; McGovern E; Raposo A; Khatiwada S; Shen S; Koentgen S; Hold G; Behary J; El-Omar E; Zekry A, 2022, 'Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.770017

Shaw S; Berry S; Thomson J; Murray GI; El-Omar E; Hold GL, 2022, 'Gut Mucosal Microbiome Signatures of Colorectal Cancer Differ According to BMI Status', Frontiers in Medicine, 8, http://dx.doi.org/10.3389/fmed.2021.800566

Susic DF; Wang L; Roberts LM; Bai M; Gia A; McGovern E; Jiang XT; Davis GK; El-Omar E; Henry A, 2022, 'The P4 Study: Postpartum Maternal and Infant Faecal Microbiome 6 Months After Hypertensive Versus Normotensive Pregnancy', Frontiers in Cellular and Infection Microbiology, 12, pp. 646165, http://dx.doi.org/10.3389/fcimb.2022.646165

Nitschke P; Lodge S; Kimhofer T; Masuda R; Bong SH; Hall D; Schäfer H; Spraul M; Pompe N; Diercks T; Bernardo-Seisdedos G; Mato JM; Millet O; Susic D; Henry A; El-Omar EM; Holmes E; Lindon JC; Nicholson JK; Wist J, 2022, 'J-Edited DIffusional Proton Nuclear Magnetic Resonance Spectroscopic Measurement of Glycoprotein and Supramolecular Phospholipid Biomarkers of Inflammation in Human Serum', Analytical Chemistry, 94, pp. 1333 - 1341, http://dx.doi.org/10.1021/acs.analchem.1c04576

Inan-Eroglu E; Huang BH; Ahmadi MN; Johnson N; El-Omar EM; Stamatakis E, 2022, 'Joint associations of adiposity and alcohol consumption with liver disease-related morbidity and mortality risk: findings from the UK Biobank', European Journal of Clinical Nutrition, 76, pp. 74 - 83, http://dx.doi.org/10.1038/s41430-021-00923-4

Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A, 2021, 'Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model', BMC Microbiology, 21, pp. 113, http://dx.doi.org/10.1186/s12866-021-02171-9

Behary J; Amorim N; Jiang XT; Raposo A; Gong L; McGovern E; Ibrahim R; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O’Sullivan J; Weltman M; McCaughan G; El-Omar E; Zekry A, 2021, 'Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma', Nature Communications, 12, pp. 187, http://dx.doi.org/10.1038/s41467-020-20422-7

Wands DIF; El-Omar EM; Hansen R, 2021, 'Helicobacter pylori: Getting to grips with the guidance', Frontline Gastroenterology, 12, pp. 650 - 655, http://dx.doi.org/10.1136/flgastro-2020-101571

Hathi Z; Mettu S; Priya A; Athukoralalage S; Lam TN; Choudhury NR; Dutta NK; El-Omar EM; Gong L; Mohan G; Lin CSK, 2021, 'Methodological advances and challenges in probiotic bacteria production: Ongoing strategies and future perspectives', Biochemical Engineering Journal, 176, http://dx.doi.org/10.1016/j.bej.2021.108199

Wu N; Mah C; Koentgen S; Zhang L; Grimm MC; El-Omar E; Hold GL, 2021, 'Inflammatory bowel disease and the gut microbiota', Proceedings of the Nutrition Society, 80, pp. 424 - 434, http://dx.doi.org/10.1017/S002966512100197X

Gong L; El-Omar EM, 2021, 'Application of molecular techniques in Helicobacter pylori detection: limitations and improvements', Helicobacter, 26, http://dx.doi.org/10.1111/hel.12841

Schupfer E; Pak SC; Wang S; Micalos PS; Jeffries T; Ooi SL; Golombick T; Harris G; El-Omar E, 2021, 'The effects and benefits of arabinoxylans on human gut microbiota – A narrative review', Food Bioscience, 43, http://dx.doi.org/10.1016/j.fbio.2021.101267

Kalasabail S; Engelman J; Zhang LY; El‐omar E; Yim HCH, 2021, 'A perspective on the role of microbiome for colorectal cancer treatment', Cancers, 13, http://dx.doi.org/10.3390/cancers13184623

Yim HCH; El-Omar EM, 2021, 'Risk of physical activity and hepatobiliary diseases: East meets west', British Journal of Sports Medicine, 55, pp. 1003 - 1004, http://dx.doi.org/10.1136/bjsports-2020-103348

Hasain Z; Raja Ali RA; Abdul Razak S; Azizan KA; El-Omar E; Razalli NH; Mokhtar NM, 2021, 'Gut Microbiota Signature Among Asian Post-gestational Diabetes Women Linked to Macronutrient Intakes and Metabolic Phenotypes', Frontiers in Microbiology, 12, http://dx.doi.org/10.3389/fmicb.2021.680622

Alemao CA; Budden KF; Gomez HM; Rehman SF; Marshall JE; Shukla SD; Donovan C; Forster SC; Yang IA; Keely S; Mann ER; El Omar EM; Belz GT; Hansbro PM, 2021, 'Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders', Allergy: European Journal of Allergy and Clinical Immunology, 76, pp. 714 - 734, http://dx.doi.org/10.1111/all.14548

Chen CC; Liou JM; Lee YC; Hong TC; El-Omar EM; Wu MS, 2021, 'The interplay between Helicobacter pylori and gastrointestinal microbiota', Gut Microbes, 13, pp. 1 - 22, http://dx.doi.org/10.1080/19490976.2021.1909459

Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AHR; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJY; Lin JT; Graham DY; Wu MS; El-Omar EM, 2020, 'Screening and eradication of Helicobacter pylori for gastric cancer prevention: The Taipei global consensus', Gut, 69, pp. 2093 - 2112, http://dx.doi.org/10.1136/gutjnl-2020-322368

Siau K; El-Omar E, 2020, 'How to write a Letter to the Editor', United European gastroenterology journal, 8, pp. 981 - 983, http://dx.doi.org/10.1177/2050640620956921

Susic D; Davis G; O'Sullivan AJ; McGovern E; Harris K; Roberts LM; Craig ME; Mangos G; Hold GL; El-Omar EM; Henry A, 2020, 'Microbiome Understanding in Maternity Study (MUMS), an Australian prospective longitudinal cohort study of maternal and infant microbiota: study protocol', BMJ Open, 10, pp. e040189, http://dx.doi.org/10.1136/bmjopen-2020-040189

Zhao R; Coker OO; Wu J; Zhou Y; Zhao L; Nakatsu G; Bian X; Wei H; Chan AWH; Sung JJY; Chan FKL; El-Omar E; Yu J, 2020, 'Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects', Gastroenterology, 159, pp. 969 - 983.e4, http://dx.doi.org/10.1053/j.gastro.2020.05.004

Donovan C; Liu G; Shen S; Marshall JE; Kim RY; Alemao CA; Budden KF; Choi JP; Kohonen-Corish M; El-Omar EM; Yang IA; Hansbro PM, 2020, 'The role of the microbiome and the NLRP3 inflammasome in the gut and lung', Journal of Leukocyte Biology, 108, pp. 925 - 935, http://dx.doi.org/10.1002/JLB.3MR0720-472RR

Kalantar-Zadeh K; Ward SA; Kalantar-Zadeh K; El-Omar EM, 2020, 'Erratum: Considering the Effects of Microbiome and Diet on SARS-CoV 2 Infection: Nanotechnology Roles (ACS Nano (2020) 14:5 (5179-5182) DOI: 10.1021/acsnano.0c03402)', ACS Nano, 14, pp. 9202, http://dx.doi.org/10.1021/acsnano.0c04407

Kalantar-Zadeh K; Ward SA; Kalantar-Zadeh K; El-Omar EM, 2020, 'Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles', ACS Nano, 14, pp. 5179 - 5182, http://dx.doi.org/10.1021/acsnano.0c03402

Hussain Z; El-Omar E; Lee YY, 2020, 'Dual infective burden of Helicobacter pylori and intestinal parasites: Good or bad news for the host?', Indian Journal of Gastroenterology, 39, pp. 111 - 116, http://dx.doi.org/10.1007/s12664-020-01045-8

Leonardi M; Hicks C; El-Assaad F; El-Omar E; Condous G, 2020, 'Endometriosis and the microbiome: a systematic review', BJOG: An International Journal of Obstetrics and Gynaecology, 127, pp. 239 - 249, http://dx.doi.org/10.1111/1471-0528.15916

Wang K; Li E; Busuttil RA; Kong JC; Pattison S; Sung JJY; Yu J; El-Omar EM; Simpson JA; Boussioutas A, 2020, 'A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer', Therapeutic Advances in Medical Oncology, 12, http://dx.doi.org/10.1177/1758835920930359

Susic D; Davis G; O' Sullivan AJ; McGovern E; Harris K; Roberts LM; Craig ME; Mangos G; Hold GL; El-Omar EM; Henry A, 2020, 'Microbiome Understanding in Maternity Study (MUMS), an Australian prospective longitudinal cohort study of maternal and infant microbiota: study protocol', BMJ open, 10

Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS, 2019, 'Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial', The Lancet Infectious Diseases, 19, pp. 1109 - 1120, http://dx.doi.org/10.1016/S1473-3099(19)30272-5

Schreiner P; Neurath MF; Ng SC; El-Omar EM; Sharara AI; Kobayashi T; Hisamatsu T; Hibi T; Rogler G, 2019, 'Mechanism-based treatment strategies for IBD: Cytokines, cell adhesion molecules, JAK inhibitors, gut flora, and more', Inflammatory Intestinal Diseases, 4, pp. 79 - 96, http://dx.doi.org/10.1159/000500721

Liou JM; Lee YC; El-Omar EM; Wu MS, 2019, 'Efficacy and long-term safety of h. Pylori eradication for gastric cancer prevention', Cancers, 11, pp. 593, http://dx.doi.org/10.3390/cancers11050593

Godlee F; Cook S; Coombes R; El-Omar E; Brown N, 2019, 'Calling time on formula milk adverts: The BMJ and our sister journals will no longer carry ads for breastmilk substitutes', BMJ (Online), 364, http://dx.doi.org/10.1136/bmj.l1200

Zhao R; Coker OO; Wu J; Zhao L; Nakatsu D; Bian X; Sung JJ; Chan FK; El-Omar EM; Yu J, 2019, '630 – Gut Microbiota Modulates the Chemopreventive Efficacy of Aspirin on Colon Cancer Through Reducing Aspirin Bioavailability', Gastroenterology, 156, pp. S - 133, http://dx.doi.org/10.1016/s0016-5085(19)37121-5

Liou J-M; Chen C-C; Lin J-T; El-Omar EM; Wu M-S, 2019, '815 – Long-Term Changes of Gut Microbiota, Antibiotic Resistance, and Metabolic Parameters After Helicobacter Pylori Eradication with Triple, Concomitant, and Bismuth Quadruple Therapies - a Multicenter Randomized Trial', Gastroenterology, 156, pp. S - 172, http://dx.doi.org/10.1016/s0016-5085(19)37221-x

Hansen R; Gibson S; De Paiva Alves E; Goddard M; MacLaren A; Karcher AM; Berry S; Collie-Duguid ESR; El-Omar E; Munro M; Hold GL, 2018, 'Adaptive response of neonatal sepsis-derived Group B Streptococcus to bilirubin', Scientific Reports, 8, pp. 6470, http://dx.doi.org/10.1038/s41598-018-24811-3

Lai ZL; Tseng CH; Ho HJ; Cheung CKY; Lin JY; Chen YJ; Cheng FC; Hsu YC; Lin JT; El-Omar EM; Wu CY, 2018, 'Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice', Scientific Reports, 8, pp. 15625, http://dx.doi.org/10.1038/s41598-018-33893-y

Liou JM; Chen PY; Luo JC; Lee JY; Chen CC; Fang YJ; Yang TH; Chang CY; Bair MJ; Chen MJ; Hsu YC; Hsu WF; Chang CC; Lin JT; Shun CT; El-Omar EM; Wu MS; Liou JM; Lee YC; Lin JT; Wu CY; Wu JY; Chen CC; Lin CH; Fang YR; Cheng TY; Tseng PH; Chiu HM; Chang CC; Yu CC; Chiu MC; Chen YN; Hu WH; Chou CK; Tai CM; Lee CT; Wang WL; Chang WS, 2018, 'Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection', Gastroenterology, 155, pp. 1109 - 1119, http://dx.doi.org/10.1053/j.gastro.2018.06.047

Wang K; Li EX; Busuttil RA; Kong JC; Pattison ST; Sung JJY; Yu J; El-Omar EM; Simpson JA; Boussioutas A, 2018, 'Differential response to adjuvant chemotherapy based on Lauren subtype affects clinical outcome of gastric cancer: A cohort study and meta-analysis.', JOURNAL OF CLINICAL ONCOLOGY, 36, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.4048

Lochhead P; El-Omar EM, 2018, 'Molecular Predictors of Gastric Neoplastic Progression', Cancer Cell, 33, pp. 9 - 11, http://dx.doi.org/10.1016/j.ccell.2017.12.006

Douglas GM; Hansen R; Jones CMA; Dunn KA; Comeau AM; Bielawski JP; Tayler R; El-Omar EM; Russell RK; Hold GL; Langille MGI; Limbergen JV, 2018, 'Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn's disease', Microbiome, 6, pp. 13, http://dx.doi.org/10.1186/s40168-018-0398-3

Wu C-Y; El-Omar EM; Tseng C-H; Lin J-T; Ho HJ, 2018, 'Su1957 - Fecal Microbiota Transplantation Confers Beneficial Metabolic Effects of Diet and Exercise on Diet-Induced Obese Mice', Gastroenterology, 154, pp. S - 646, http://dx.doi.org/10.1016/s0016-5085(18)32303-5

Rugge M; Genta RM; Di Mario F; El-Omar EM; El-Serag HB; Fassan M; Hunt RH; Kuipers EJ; Malfertheiner P; Sugano K; Graham DY, 2017, 'Gastric Cancer as Preventable Disease', Clinical Gastroenterology and Hepatology, 15, pp. 1833 - 1843, http://dx.doi.org/10.1016/j.cgh.2017.05.023

Kuo YT; Liou JM; El-Omar EM; Wu JY; Leow AHR; Goh KL; Das R; Lu H; Lin JT; Tu YK; Yamaoka Y; Wu MS, 2017, 'Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis', The Lancet Gastroenterology and Hepatology, 2, pp. 707 - 715, http://dx.doi.org/10.1016/S2468-1253(17)30219-4

Berry SH; El-Omar EM; Hold GL; Mukhopadhya A, 2017, 'THE EFFECT OF LACTULOSE ON THE FAECAL MICROBIOTA OF PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY', GASTROENTEROLOGY, 152, pp. S1049 - S1049, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000403140304299&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Malfertheiner P; Megraud F; O'Morain CA; Gisbert JP; Kuipers EJ; Axon AT; Bazzoli F; Gasbarrini A; Atherton J; Graham DY; Hunt R; Moayyedi P; Rokkas T; Rugge M; Selgrad M; Suerbaum S; Sugano K; El-Omar EM; Agreus L; Andersen LP; Atherton J; Axon A; Bazzoli F; Coelho L; Delchier JC; Di Mario F; Dinis-Ribeiro M; El-Omar E; Fischbach W; Flahou B; Fock KM; Gasbarrini A; Gasbarrini G; Gensini G; Gisbert J; Goh KL; Graham DY; Herrero R; Hunt R; Kuipers EJ; Kupcinskas L; Lanas A; Leja M; Machado JC; Mahachai V; Malfertheiner P; Megraud F; Milosavljevic T; Moayyedi P; Molina-Infante J; Niv Y; O'Morain C; Ristimaki A; Rokkas T; Rugge M; Selgrad M; Suerbaum S; Sugano K; Tepes B; Vaira D; Vieth M; You W, 2017, 'Management of helicobacter pylori infection-the Maastricht V/Florence consensus report', Gut, 66, pp. 6 - 30, http://dx.doi.org/10.1136/gutjnl-2016-312288

Watt E; Gemmell MR; Berry S; Glaire M; Farquharson F; Louis P; Murray GI; El-Omar E; Hold GL, 2016, 'Extending colonic mucosal microbiome analysis-assessment of colonic lavage as a proxy for endoscopic colonic biopsies', Microbiome, 4, pp. 61, http://dx.doi.org/10.1186/s40168-016-0207-9

Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS, 2016, 'Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial', The Lancet, 388, pp. 2355 - 2365, http://dx.doi.org/10.1016/S0140-6736(16)31409-X

Mukhopadhya I; Murray GI; Duncan L; Yuecel R; Shattock R; Kelly C; Iannelli F; Pozzi G; El-Omar EM; Hold GL; Hijazi K, 2016, 'Transporters for antiretroviral drugs in colorectal CD4+ T cells and circulating α4β7 integrin CD4+ T cells: Implications for HIV microbicides', Molecular Pharmaceutics, 13, pp. 3334 - 3340, http://dx.doi.org/10.1021/acs.molpharmaceut.6b00351

Back to profile page